{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:12:11Z","timestamp":1792098731555,"version":"4.4.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatol Commun"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Nonalcoholic fatty liver disease (NAFLD) is prevalent worldwide. NAFLD is associated with elevated serum triglycerides (TG), low\u2010density lipoprotein cholesterol (LDL), and reduced high\u2010density lipoprotein cholesterol (HDL). Both NAFLD and blood lipid levels are genetically influenced and may share a common genetic etiology. We used genome\u2010wide association studies (GWAS)\u2013ranked genes and gene\u2010set enrichment analysis to identify pathways that affect serum lipids and NAFLD. We identified credible genes in these pathways and characterized missense variants in these for effects on serum traits. We used MAGENTA to identify 58 enriched pathways from publicly available TG, LDL, and HDL GWAS (n\u00a0=\u00a099,000). Three of these pathways were also enriched for associations with European\u2010ancestry NAFLD GWAS (n\u00a0=\u00a07176). One pathway, farnesoid X receptor (FXR)\/retinoid X receptor (RXR) activation, was replicated for association in an African\u2010ancestry NAFLD GWAS (n\u00a0=\u00a03214) and plays a role in serum lipids and NAFLD. Credible genes (proteins) in FXR\/RXR activation include those associated with cholesterol\/bile\/bilirubin transport\/absorption (<jats:italic toggle=\"yes\">ABCC2<\/jats:italic> (MRP2) [ATP binding cassette subfamily C member (multidrug resistance\u2010associated protein 2)], <jats:italic toggle=\"yes\">ABCG5<\/jats:italic>, <jats:italic toggle=\"yes\">ABCG8<\/jats:italic> [ATP\u2010binding cassette (ABC) transporters G5 and G8], <jats:italic toggle=\"yes\">APOB<\/jats:italic> (APOB) [apolipoprotein B], <jats:italic toggle=\"yes\">FABP6<\/jats:italic> (ILBP) [fatty acid binding protein 6 (ileal lipid\u2010binding protein)], <jats:italic toggle=\"yes\">MTTP<\/jats:italic> (MTP) [microsomal triglyceride transfer protein], <jats:italic toggle=\"yes\">SLC4A2<\/jats:italic> (AE2) [solute carrier family 4 member 2 (anion exchange protein 2)]), nuclear hormone\u2013mediated control of metabolism (<jats:italic toggle=\"yes\">NR0B2<\/jats:italic> (SHP) [nuclear receptor subfamily 0 group B member 2 (small heterodimer partner)], <jats:italic toggle=\"yes\">NR1H4<\/jats:italic> (FXR) [nuclear receptor subfamily 1 group H member 4 (FXR)], <jats:italic toggle=\"yes\">PPARA<\/jats:italic> (PPAR) [peroxisome proliferator activated receptor alpha], <jats:italic toggle=\"yes\">FOXO1<\/jats:italic> (FOXO1A) [forkhead box O1]), or other pathways (<jats:italic toggle=\"yes\">FETUB<\/jats:italic> (FETUB) [fetuin B]). Missense variants in <jats:italic toggle=\"yes\">ABCC2<\/jats:italic> (MRP2), <jats:italic toggle=\"yes\">ABCG5<\/jats:italic> (ABCG5), <jats:italic toggle=\"yes\">ABCG8<\/jats:italic> (ABCG8), <jats:italic toggle=\"yes\">APOB<\/jats:italic> (APOB), <jats:italic toggle=\"yes\">MTTP<\/jats:italic> (MTP), <jats:italic toggle=\"yes\">NR0B2<\/jats:italic> (SHP), <jats:italic toggle=\"yes\">NR1H4<\/jats:italic> (FXR), and <jats:italic toggle=\"yes\">PPARA<\/jats:italic> (PPAR) that associate with serum LDL levels also associate with serum liver function tests in UK Biobank. <jats:italic toggle=\"yes\">Conclusion<\/jats:italic>: Genetic variants in <jats:italic toggle=\"yes\">NR1H4<\/jats:italic> (FXR) that protect against liver steatosis increase serum LDL cholesterol while variants in other members of the family have congruent effects on these traits. Human genetic pathway enrichment analysis can help guide therapeutic development by identifying effective targets for NAFLD\/serum lipid manipulation while minimizing side effects. In addition, missense variants could be used in companion diagnostics to determine their influence on drug effectiveness.<\/jats:p>","DOI":"10.1002\/hep4.2066","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T12:08:52Z","timestamp":1663070932000},"page":"3120-3131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Population\u2010based meta\u2010analysis and gene\u2010set enrichment identifies FXR\/RXR pathway as common to fatty liver disease and serum lipids"],"prefix":"10.1097","volume":"6","author":[{"given":"Samuel K.","family":"Handelman","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan Health System,Ann Arbor,Michigan,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yindra M.","family":"Puentes","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan Health System,Ann Arbor,Michigan,USA"},{"name":"Department of Computational Medicine and Bioinformatics,University of Michigan Medical School,Ann Arbor,Michigan,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapurna","family":"Kuppa","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan Health System,Ann Arbor,Michigan,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan Health System,Ann Arbor,Michigan,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Du","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan Health System,Ann Arbor,Michigan,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Feitosa","sequence":"additional","affiliation":[{"name":"Division of Statistical Genomics, Department of Genetics,Washington University,St. Louis,Missouri,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholette D.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Department of Biochemistry,Wake Forest School of Medicine,Winston\u2010Salem,North Carolina,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1002-4140","authenticated-orcid":false,"given":"Elizabeth K.","family":"Speliotes","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology,University of Michigan Health System,Ann Arbor,Michigan,USA"},{"name":"Department of Computational Medicine and Bioinformatics,University of Michigan Medical School,Ann Arbor,Michigan,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"hep42066-bib-0001-20241104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep42066-bib-0002-20241104","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","article-title":"Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"hep42066-bib-0003-20241104","article-title":"genome\u2010wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","year":"2011","journal-title":"PLoS Genet"},{"key":"hep42066-bib-0004-20241104","article-title":"Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits","volume":"6","year":"2010","journal-title":"PLoS Genet"},{"key":"hep42066-bib-0005-20241104","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","year":"2010","journal-title":"Nature"},{"key":"hep42066-bib-0006-20241104","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.26440","article-title":"Characterization of European ancestry nonalcoholic fatty liver disease\u2010associated variants in individuals of African and Hispanic descent","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"hep42066-bib-0007-20241104","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/01.TP.0000140499.23683.0D","article-title":"Noninvasive evaluation of graft steatosis in living donor liver transplantation","volume":"78","year":"2004","journal-title":"Transplantation"},{"key":"hep42066-bib-0008-20241104","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analysis of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","year":"2010","journal-title":"Nat Genet"},{"key":"hep42066-bib-0009-20241104","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.685","article-title":"Meta\u2010analysis identifies 13 new loci associated with waist\u2010hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution","volume":"42","year":"2010","journal-title":"Nat Genet"},{"key":"hep42066-bib-0010-20241104","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","year":"2011","journal-title":"Nature"},{"key":"hep42066-bib-0011-20241104","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","year":"2015","journal-title":"PLoS Med"},{"key":"hep42066-bib-0012-20241104","article-title":"ANNOVAR: functional annotation of genetic variants from high\u2010throughput sequencing data","volume":"38","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"hep42066-bib-0013-20241104","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/s41588-018-0255-0","article-title":"Distinguishing genetic correlation from causation across 52 diseases and complex traits","volume":"50","year":"2018","journal-title":"Nat Genet"},{"key":"hep42066-bib-0014-20241104","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/bioinformatics\/btw613","article-title":"LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis","volume":"33","year":"2017","journal-title":"Bioinformatics"},{"key":"hep42066-bib-0015-20241104","first-page":"564","article-title":"Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men","volume":"35","year":"1988","journal-title":"Dan Med Bull"},{"key":"hep42066-bib-0016-20241104","article-title":"Generalization and dilution of association results from European GWAS in populations of non\u2010European ancestry: the PAGE study","volume":"11","year":"2013","journal-title":"PLoS Biol"},{"key":"hep42066-bib-0017-20241104","article-title":"Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease","volume":"12","year":"2011","journal-title":"BMC Med Genet"},{"key":"hep42066-bib-0018-20241104","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter\u2010organ cross\u2010talk in metabolic syndrome","volume":"1","year":"2019","journal-title":"Nat Metab"},{"key":"hep42066-bib-0019-20241104","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3892\/etm.2011.328","article-title":"Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L\u2010FABP in non\u2010alcoholic fatty liver disease","volume":"2","year":"2011","journal-title":"Exp Ther Med"},{"key":"hep42066-bib-0020-20241104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jmg.39.3.189","article-title":"A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is associated with variations in serum lipid levels","volume":"39","year":"2002","journal-title":"J Med Genet"},{"key":"hep42066-bib-0021-20241104","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","year":"2006","journal-title":"J Clin Invest"},{"key":"hep42066-bib-0022-20241104","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPARalpha\u2010dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","year":"2003","journal-title":"Hepatology"},{"key":"hep42066-bib-0023-20241104","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non\u2010alcoholic fatty liver disease","volume":"40","year":"2008","journal-title":"Dig Liver Dis"},{"key":"hep42066-bib-0024-20241104","doi-asserted-by":"crossref","first-page":"48275","DOI":"10.1074\/jbc.M310223200","article-title":"ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"hep42066-bib-0025-20241104","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1161\/ATVBAHA.111.236075","article-title":"The cholesterol content of Western diets plays a major role in the paradoxical increase in high\u2010density lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway","volume":"31","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"hep42066-bib-0026-20241104","doi-asserted-by":"crossref","first-page":"16237","DOI":"10.1073\/pnas.252582399","article-title":"Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion","volume":"99","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"hep42066-bib-0027-20241104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2036.1988.tb00678.x","article-title":"Effect of oral testosterone treatment on serum concentrations of sex steroids gonadotrophins and prolactin in alcoholic cirrhotic men. Copenhagen Study Group for Liver Diseases","volume":"2","year":"1988","journal-title":"Aliment Pharmacol Ther"},{"key":"hep42066-bib-0028-20241104","article-title":"Non\u2010alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients","volume":"7","year":"2017","journal-title":"Sci Rep"},{"key":"hep42066-bib-0029-20241104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/BJ20070658","article-title":"The farnesoid X receptor induces fetuin\u2010B gene expression in human hepatocytes","volume":"407","year":"2007","journal-title":"Biochem J"},{"key":"hep42066-bib-0030-20241104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","article-title":"Impact of obeticholic acid on the lipoprotein profile in patients with non\u2010alcoholic steatohepatitis","volume":"72","year":"2020","journal-title":"J Hepatol"},{"key":"hep42066-bib-0031-20241104","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/joim.12594","article-title":"Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C\u2010III","volume":"281","year":"2017","journal-title":"J Intern Med"},{"key":"hep42066-bib-0032-20241104","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejphar.2017.11.021","article-title":"Obeticholic acid raises LDL\u2010cholesterol and reduces HDL\u2010cholesterol in the Diet\u2010Induced NASH (DIN) hamster model","volume":"818","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"hep42066-bib-0033-20241104","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/dom.12681","article-title":"Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers","volume":"18","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"hep42066-bib-0034-20241104","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/jdi.12621","article-title":"Selective peroxisome proliferator\u2010activated receptor\u2010alpha modulator K\u2010877 efficiently activates the peroxisome proliferator\u2010activated receptor\u2010alpha pathway and improves lipid metabolism in mice","volume":"8","year":"2017","journal-title":"J Diabetes Investig"},{"key":"hep42066-bib-0035-20241104","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4254\/wjh.v5.i9.470","article-title":"Current role of fenofibrate in the prevention and management of non\u2010alcoholic fatty liver disease","volume":"5","year":"2013","journal-title":"World J Hepatol"},{"key":"hep42066-bib-0036-20241104","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","article-title":"Role of nuclear receptor SHP in metabolism and cancer","volume":"1812","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"hep42066-bib-0037-20241104","article-title":"MTTP\u2010297H polymorphism reduced serum cholesterol but increased risk of non\u2010alcoholic fatty liver disease\u2010a cross\u2010sectional study","volume":"16","year":"2015","journal-title":"BMC Med Genet"},{"key":"hep42066-bib-0038-20241104","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCULATIONAHA.117.028208","article-title":"Long\u2010term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia","volume":"136","year":"2017","journal-title":"Circulation"},{"key":"hep42066-bib-0040-20241104","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2013.11.010","article-title":"ABCG5\/ABCG8 in cholesterol excretion and atherosclerosis","volume":"428","year":"2014","journal-title":"Clin Chim Acta"},{"key":"hep42066-bib-0041-20241104","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0216001","article-title":"Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol","volume":"110","year":"2002","journal-title":"J Clin Invest"},{"key":"hep42066-bib-0042-20241104","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.3748\/wjg.v12.i22.3496","article-title":"Cholangiocyte anion exchange and biliary bicarbonate excretion","volume":"12","year":"2006","journal-title":"World J Gastroenterol"},{"key":"hep42066-bib-0043-20241104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2016.11.009","article-title":"PPARs and nonalcoholic fatty liver disease","volume":"136","year":"2017","journal-title":"Biochimie"},{"key":"hep42066-bib-0044-20241104","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/hep.20170","article-title":"Administration of the potent PPARalpha agonist, Wy\u201014643, reverses nutritional fibrosis and steatohepatitis in mice","volume":"39","year":"2004","journal-title":"Hepatology"},{"key":"hep42066-bib-0045-20241104","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4239\/wjd.v7.i5.74","article-title":"Use of fibrates in the metabolic syndrome: a review","volume":"7","year":"2016","journal-title":"World J Diabetes"},{"key":"hep42066-bib-0046-20241104","first-page":"541","article-title":"Small heterodimer partner (SHP) contributes to insulin resistance in cardiomyocytes","volume":"1862","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"hep42066-bib-0047-20241104","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1262-3636(08)74599-3","article-title":"The role of the lipogenic pathway in the development of hepatic steatosis","volume":"34","year":"2008","journal-title":"Diabetes Metab"},{"key":"hep42066-bib-0048-20241104","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","year":"2018","journal-title":"Gut"},{"key":"hep42066-bib-0049-20241104","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00535-015-1041-8","article-title":"Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa","volume":"50","year":"2015","journal-title":"J Gastroenterol"},{"key":"hep42066-bib-0050-20241104","article-title":"Genome\u2010wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA","volume":"7","year":"2016","journal-title":"Nat Commun"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.2066","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.2066","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.2066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T08:01:38Z","timestamp":1730707298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.2066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.2066","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"2022-07-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}